RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study was to determine if intravitreal ranibizumab is superior to laser ablation therapy in the treatment of retinopathy of prematurity (ROP).
Epistemonikos ID: 7d683c282d5f2dbaa5dd7964845e233d6f586bdb
First added on: May 12, 2024